Atlas Trials

Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Migalastat in Pediatric Subjects (Aged 12 to <18 Years)

Clinical trial NCT03500094 · COMPLETED

Trial details

NCT number
NCT03500094
Sponsor
Amicus Therapeutics
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Fabry Disease
Start date
2018-09-27
Primary completion
2021-02-02
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.